India is in all likelihood to have an indigenous Covid-19 vaccine for kids by September, Indian Council of Medical Research (ICMR)’s National Institute of Virology (Pune) director Priya Abraham has stated amid the continued section II and III trials of Covaxin for the 2-18 age group.
“Hopefully, the outcomes (of the trials) are going to be had very soon. The outcomes can be provided to the regulators. So, by September or simply after it, we can also additionally have Covid-19 vaccines for kids,” Abraham stated in an interview with India Science, an OTT channel of the technology and era department.
ICMR and Hyderabad-primarily based vaccine producer Bharat Biotech co-advanced Covaxin, India’s first indigenous Covid-19 vaccine. Covaxin is one of the 3 vaccines being administered in India below the countrywide Covid-19 immunisation programme. The differences are Serum Institute of India’s Covishield, and the Russian Sputnik V.